Anavex Life Sciences Corp (AVXL)

[georgejjl]

The ANAVEX 2-73 trials are proceeding as planned

ANAVEX®2-73 Program Update:

Since enrollment started on October 30, 2018 for the Phase 2 ANAVEX®2-73 Parkinson’s disease dementia (PDD) study[1], over one-third of the total patient enrollment target has been achieved to date.

Enrollment for the Phase 2b/3 ANAVEX®2-73 Alzheimer’s disease (AD) study[2] is proceeding as planned with over 80 patients screened to date.

Successfully submitted Phase 2 ANAVEX®2-73 Rett syndrome (RTT) study[3] to respective United States Institutional Review Boards (IRB) of the first three clinical trial sites.

https://www.anavex.com/anavex-life-sciences-reports-fiscal-2019-first-quarter-financial-results-and-provides-clinical-study-updates/

Good luck and GOD bless,